top of page

Leading genomic innovation beyond traditional boundaries

We detectwhat others cannot see.

Our groundbreaking technology is designed to fill essential gaps in genomics research, diagnostics, therapeutics, and drug development.

 

Our innovative method identifies genomic data and modifications inaccessible with other commercial technologies.

 

Our distinctive platform does not require DNA amplification, labels, or library preparation.

We detectwhat others cannot see

DNA
DNA Chips
Scientist using microscope
Illuminated Abstract Shapes

Research & Technology

Using the power of machine learning we have:

  • Developed rapidly manufacturable metamaterial/plasmonic nanostructures with outstanding sensitivity for non-resonant SERS single nucleotide detection.

 

  • Demonstrated our detection of single nucleotides.

 

  • Integrated our structures into chips, where we control velocity with electric fields.

What We Stand For

Innovation, Health, Humanity

Our promise is to

provide a wealth of new genomic data to greatly improve patients' lives.

- Emily Milsovic, CEO

SF109987-Edit-Wide.jpg

Facilities & World-Class Partners 

Screenshot 2024-09-13 at 3.11.42 PM.png
Screenshot 2024-09-13 at 3.11.42 PM.png

Armonica Tech., San Diego laboratories

Screenshot 2024-09-13 at 3.15.26 PM.png

Armonica’s Center on the University of New Mexico campus

326386530_1303243507191480_3261310425976933804_n_edited.jpg

Center for High Technology Materials (CHTM/UNM) Facilities

cint-buildings-sandia.jpg

Center for Integrated Nanotechnologies (Sandia and Los Alamos National Laboratories)

UC-San-Diego-Health-Sciences-Biomedical-Research-Facility-2-100.jpg.webp

UCSD Nano3 facility at the University of California-San Diego

Join Our Team

We’re looking for highly-motivated and talented people to join our innovative team. Submit your application today to join the Armonica journey!

Join the Armonica community

Be the first to receive the latest news and updates.

Problem

Current genomic analysis methods often miss critical epigenetic data and important genomic markers, leading to significant diagnostic gaps.

Solution

Detect of large structural variants, long range epigenetic mapping, and de novo genome assembly

Sequence ultra-long, native nucleic acid molecules at single base resolution

No labeling or amplification of target nucleic acid is required, and the sequence is read in real-time.

In the Press

Emily Milsovic: Pioneering Genomic Innovation

CIO Views

Oct 2024

Armonica Technologies announces Emily Milsovic joins Board of Directors 

PR Newswire

Feb 26, 2024

Armonica Technologies announces Todd Dickinson joins Board of Directors

Yahoo! Finance

March 13, 2024

Armonica Technologies Awarded NIH Grant 

PR Newswire

Aug 31, 2022

bottom of page